Advertisement

Topics

Insulet Corporation Company Profile

15:52 EDT 25th March 2019 | BioPortfolio

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its Omnipod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The Omnipod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and a fully-automated cannula insertion. Insulet's Delivery Systems business also partners with global pharmaceutical and biotechnology companies to tailor the Omnipod technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas. Founded in 2000, Insulet Corporation is based in Billerica, Massachusetts. For more information, please visit: http://www.myomnipod.com.


News Articles [135 Associated News Articles listed on BioPortfolio]

TUV Rheinland helps Insulet’s insulin pump secure cybersecurity certification by DTSec

This distinction goes to Insulet Corporation’s Omnipod DASH Insulin Management System. As the DTSec Accredited Lab, TUV Rheinland OpenSky was engaged to evaluate and test Insulet Corporation’s Omn...

Insulet promotes president, COO to CEO

Shacey Petrovic, president and chief operating officer at Insulet, has been tapped by the company to serve as its CEO and on  -More- 

Insulet, Samsung team up on Omnipod-Galaxy integration

Samsung and Insulet are partnering to allow the latter's Omnipod Dash Insulin Management System to be controlled by Samsung G -More- 

Samsung Galaxy smartphones to control Insulet’s Omnipod insulin system

If approved, the Omnipod system will allow consumer to use their personal Galaxy smartphone to securely control their insulin pump therapy. Insulet president and COO Shacey Petrovic said: The post Sa...

Insulet to Present at the 37th Annual J.P. Morgan Healthcare Conference

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management w...

Insulet to Announce Third Quarter 2018 Financial Results on November 1, 2018

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today annou...

Insulet to Announce Fourth Quarter and Full Year 2018 Financial Results on February 25, 2019

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today annou...

Insulet (PODD) Q3 2018 Results - Earnings Call Transcript

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Insulet Artificial Pancreas Free-Living IDE3

Subjects will undergo a 7±1 day outpatient, standard therapy phase during which sensor and insulin data will be collected. Subjects or their caregivers will manage their diabetes at home ...

Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal Impairment

CNDP-578-02 is a randomized, double-blind, placebo-controlled, dose-escalation, crossover design trial. Eight evaluable subjects (n=8) with chronic stable heart failure and moderate renal ...

Companies [180 Associated Companies listed on BioPortfolio]

Insulet Corporation

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its Omnipod Insulin Management Sys...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

Protective Life Corporation

Protective Life Corporation provides financial services through the production, distribution and administration of insurance and investment products throughout the U.S. The compan...

Immusoft Corporation

Immusoft Corporation’s (immusoft.com) mission is to treat diseases using its breakthrough technology platform called Immune System Programming (ISP™). The technology mod...

More Information about "Insulet Corporation" on BioPortfolio

We have published hundreds of Insulet Corporation news stories on BioPortfolio along with dozens of Insulet Corporation Clinical Trials and PubMed Articles about Insulet Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Insulet Corporation Companies in our database. You can also find out about relevant Insulet Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record